Literature DB >> 11173037

Streptococcus pneumoniae: new tools for an old pathogen.

S K Hollingshead1, D E Briles.   

Abstract

The pneumococcus is one of the longest-known pathogens. It has been instrumental to our understanding of biology in many ways, such as in the discovery of the Gram strain and the identification of nucleic acid as the hereditary material. Despite major advances in our understanding of pneumococcal pathogenesis, the need for vaccines and antibiotics to combat this pathogen is still vital. Genomics is beginning to uncover new virulence factors to advance this process, and it is enabling the development of DNA chip technology, which will permit the analysis of gene expression in specific tissues and in virulence regulatory circuits.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11173037     DOI: 10.1016/s1369-5274(00)00167-3

Source DB:  PubMed          Journal:  Curr Opin Microbiol        ISSN: 1369-5274            Impact factor:   7.934


  6 in total

1.  Characterization, distribution, and expression of novel genes among eight clinical isolates of Streptococcus pneumoniae.

Authors:  Kai Shen; John Gladitz; Patricia Antalis; Bethany Dice; Benjamin Janto; Randy Keefe; Jay Hayes; Azad Ahmed; Richard Dopico; Nathan Ehrlich; Jennifer Jocz; Laura Kropp; Shujun Yu; Laura Nistico; David P Greenberg; Karen Barbadora; Robert A Preston; J Christopher Post; Garth D Ehrlich; Fen Z Hu
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

2.  Leukotriene B4 receptor type 2 protects against pneumolysin-dependent acute lung injury.

Authors:  Misako Shigematsu; Tomoaki Koga; Ayako Ishimori; Kazuko Saeki; Yumiko Ishii; Yoshitaka Taketomi; Mai Ohba; Airi Jo-Watanabe; Toshiaki Okuno; Norihiro Harada; Takeshi Harayama; Hideo Shindou; Jian-Dong Li; Makoto Murakami; Sumio Hoka; Takehiko Yokomizo
Journal:  Sci Rep       Date:  2016-10-05       Impact factor: 4.379

3.  Increased Systemic Cytokine/Chemokine Expression in Asthmatic and Non-asthmatic Patients with Bacterial, Viral or Mixed Lung Infection.

Authors:  M J Giuffrida; N Valero; J Mosquera; A Duran; F Arocha; B Chacín; L M Espina; J Gotera; J Bermudez; A Mavarez; M Alvarez-Mon
Journal:  Scand J Immunol       Date:  2017-04       Impact factor: 3.487

4.  PspA family distribution, antimicrobial resistance and serotype of Streptococcus pneumoniae isolated from upper respiratory tract infections in Japan.

Authors:  Muneki Hotomi; Akihisa Togawa; Masamitsu Kono; Yorihiko Ikeda; Shin Takei; Susan K Hollingshead; David E Briles; Kenji Suzuki; Noboru Yamanaka
Journal:  PLoS One       Date:  2013-03-06       Impact factor: 3.240

5.  β-sitosterol interacts with pneumolysin to prevent Streptococcus pneumoniae infection.

Authors:  Hongen Li; Xiaoran Zhao; Jianfeng Wang; Yu Dong; Song Meng; Rui Li; Xiaodi Niu; Xuming Deng
Journal:  Sci Rep       Date:  2015-12-03       Impact factor: 4.379

Review 6.  Surface Proteoglycans as Mediators in Bacterial Pathogens Infections.

Authors:  Beatriz García; Jesús Merayo-Lloves; Carla Martin; Ignacio Alcalde; Luis M Quirós; Fernando Vazquez
Journal:  Front Microbiol       Date:  2016-02-24       Impact factor: 5.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.